Pitavastatin是HMG-CoA还原酶的竞争性抑制剂。
Pitavastatin calcium is a novel member of the medication class of statins.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ahmad H, et al. Cardiol Rev, 2010, 18(5):264-267.
分子式 C50H46CaF2N2O8 |
分子量 880.98 |
CAS号 147526-32-7 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 50 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02056847 | HbA1c Level Associated With Lipid Compositions | Drug: Pitavastatin calcium 4mg|Drug: Pitavastatin calcium 2mg | JW Pharmaceutical|The Catholic University of Korea|Kyunghee University Medical Center|Korea University Guro Hospital|Dong-A University Hospital|Seoul National University Bundang Hospital|Samsung Medical Center|Seoul National University Hospital|Ajou University School of Medicine|Gangnam Severance Hospital|Severance Hospital|Yeungnam University|Ulsan University Hospital|Eulji University Hospital|Asan Medical Center|Chonnam National University Hospital|Chonbuk National University Hospital|Chungnam National University Hospital|Hallym University Medical Center | Phase 4 | 2014-01-01 | 2017-03-08 |
NCT00344370 | Type II Diabetes Mellitus|Dyslipidemia | Drug: Pitavastatin|Drug: Atorvastatin | Kowa Research Europe | Phase 3 | 2006-08-01 | 2010-01-25 |
NCT00309751 | Type II Diabetes Mellitus|Dyslipidemia | Drug: Pitavastatin|Drug: Atorvastatin | Kowa Research Europe | Phase 3 | 2005-12-01 | 2010-02-17 |
NCT00889226 | Hypercholesterolemia With Type2DM | Drug: Pitavastatin|Drug: Atorvastatin | JW Pharmaceutical | Phase 4 | 2008-04-01 | 2013-04-02 |
NCT01386853 | Hyperlipidemia | Drug: Pitavastatin|Drug: Atorvastatin | Tai Tien Pharmaceuticals Co., Ltd. | Phase 3 | 2011-07-01 | 2011-06-30 |
NCT01648829 | Coronary Artery Disease | Drug: Atorvastatin|Drug: Pitavastatin | University of Roma La Sapienza | Phase 4 | 2014-01-01 | 2013-03-06 |
NCT02863185 | Chronic Kidney Disease | Drug: Pitavastatin|Drug: Atorvastatin | Dong-A University | Phase 4 | 2016-05-01 | 2016-08-14 |
NCT02940366 | Metabolic Syndrome | Drug: Pitavastatin 4 mg orally daily|Drug: Atorvastatin 20 mg orally daily | Seoul National University Hospital|JW Pharmaceutical | Phase 4 | 2016-12-01 | 2017-02-08 |
NCT00861861 | Hypercholesterolemia|Coronary Artery Disease | Drug: Pitavastatin|Drug: Atorvastatin | Kumamoto University | Phase 4 | 2008-09-01 | 2013-10-11 |
NCT00249249 | Primary Hypercholesterolemia|Dyslipidemia | Drug: Pitavastatin|Drug: Atorvastatin | Kowa Research Europe | Phase 3 | 2005-10-01 | 2010-01-07 |
NCT01223586 | Statin|Coronary Plaque|Acute Coronary Syndrome|Intravascular Ultrasound|Cardiovascular Events | Kyoto University|Yamaguchi University Hospital | 2010-11-01 | 2012-04-21 | ||
NCT01710007 | Hypercholesterolemia | Drug: 1PC002|Drug: Lipitor | Orient Pharma Co., Ltd.|Orient Europharma Co., Ltd. | Phase 3 | 2011-11-01 | 2013-06-14 |
NCT01660191 | Hypercholesterolemia | Drug: Pitavastin 4mg|Drug: Atorvastatin 20mg|Drug: Rosuvastatin 5mg | University of Kansas Medical Center|Kowa Pharmaceuticals America, Inc.|Eli Lilly and Company | Phase 4 | 2011-12-01 | 2016-11-22 |
NCT00242944 | Coronary Disease|Hypercholesterolemia | Drug: Pitavastatin|Drug: Atorvastatin | Kyoto University|Yamaguchi University Hospital|Juntendo University School of Medicine | Phase 4 | 2005-11-01 | 2009-12-16 |
NCT01166633 | Hypercholesterolemia | Drug: pitavastatin|Drug: atorvastatin | JW Pharmaceutical | Phase 4 | 2009-06-01 | 2013-04-02 |
NCT01178853 | Healthy | Drug: Warfarin|Drug: Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)|Drug: Warfarin 5 mg + Pitavastatin 4mg once daily (QD) | Kowa Research Institute, Inc. | Phase 4 | 2010-07-01 | 2012-09-06 |
NCT00549926 | Coronary Disease|Hypercholesterolemia | Drug: Fluvastatin|Drug: Pravastatin|Drug: Pitavastatin|Drug: Atorvastatin | Yokohama City University Medical Center | Phase 4 | 2007-10-01 | 2010-02-16 |
NCT00716846 | Healthy Volunteers | Drug: simvastatin|Drug: atorvastatin|Drug: pitavastatin | Hamamatsu University | 2006-06-01 | 2011-09-05 | |
NCT01422382 | Healthy | Drug: Pitavastatin (NK-104)|Drug: Diltiazem (Cardizem LA) 240 mg QD | Kowa Research Institute, Inc. | Phase 4 | 2011-05-01 | 2012-07-05 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们